发明名称 Method for preparation of a N-terminally modified chemotactic factor
摘要 <p>Preparing pyroGlu-MCP-1 (A; MCP = monocyte chemoattractant protein-1) from recombinant Gln-MCP-1 (B) by incubating (B) at 30-80 [deg] C in a buffer, of pH 2-7.5, that contains 10-160 mM salt until at least 90% of MCP-1 is converted to (A). ACTIVITY : Cardiant; Vasotropic; Cerebroprotective. MECHANISM OF ACTION : CCR2 agonist; CCR4 agonist. MCP-1 is an agonist of the beta -chemokine receptors CCR2 and 4, which are involved in activation of monocytes and adhesion of integrins, resulting in bonding of monocytes to endothelial cells. This causes extravasation of monocytes from the vascular system, and thus growth of collateral and/or other arteries.</p>
申请公布号 EP1473304(A1) 申请公布日期 2004.11.03
申请号 EP20030010014 申请日期 2003.05.02
申请人 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG 发明人 SEIDLER, RANDOLPH;LENTER, MARTIN;DOODS, HENRI;WANDL, ROBERT;NECINA, ROMAN
分类号 A61K38/00;A61P9/00;C07K14/52;C12N15/19;(IPC1-7):C07K14/52;A61K38/19 主分类号 A61K38/00
代理机构 代理人
主权项
地址